NKT Therapeutics

About:

NKT Therapeutics is a privately held biotechnology company focused on developing therapeutics to treat cancer and other serious diseases.

Website: http://www.nktrx.com

Top Investors: SV Health Investors, MedImmune Ventures

Description:

NKT Therapeutics is a privately held biotechnology company focused on developing therapeutics based on unique immune cells called natural killer T (NKT) cells. The company's mission is to use its expertise to develop a pipeline of first-in-class NKT-based therapeutics to treat cancer, infectious diseases, autoimmune diseases, asthma and dermatitis.

Total Funding Amount:

$12M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)nktrx.com

Founders:

Mark Tepper

Number of Employees:

1-10

Last Funding Date:

2016-12-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai